Adverum Biotechnologies Announces $127.5 Million Private Placement Financing

REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that it has agreed to sell approximately 106.25 million shares of its common stock…Read More

Read More
Zum Raises $140M in E Round Led by GIC

REDWOOD CITY, Calif., Jan. 31, 2024 – Zūm, the leading provider of modern student transportation, today announced a $140 million Series E funding round. This new funding round was led by GIC, a leading global investment firm. Climate Investment, a decarbonization investor, and existing investors including Sequoia and SoftBank Vision Fund 2 also participated in…Read More

Read More
LogicMark Launches 2 Products, Care Village Platform and Web App

FLG partner Mark Archer, CFO at LogicMark (Nasdaq: LGMK) was delighted to help ring the market closing bell from Nasdaq’s headquarters in NYC as the company celebrated the December 2023 launch of its two new products, a SaaS medical mobile alert device (the Freedom Alert Plus) for the B-to-C market of seniors and…Read More

Read More
Lassen Therapeutics Closes $85M Oversubscribed Series B Financing

San Diego, CA, December 19, 2023 – Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics, today announced the closing of an oversubscribed Series B financing which raised $85 million. Frazier Life Sciences co-led the financing along with new investor Longitude Capital. The syndicate also included new investors BVF…Read More

Read More
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing

SAN MATEO, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced it has raised over $31 million in a Series F financing to accelerate the commercial adoption of a neurovascular intervention…Read More

Read More